(18)F-FDG PET "Metabolic Response" to Neoadjuvant Systemic Therapy for Breast Cancer: Quo Vadis? Gebhart G. J Nucl Med 2023;64:1697-1698.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gebhart G. (18)F-FDG PET "Metabolic Response" to Neoadjuvant Systemic Therapy for Breast Cancer: Quo Vadis? J Nucl Med 2023;64:1697-1698.
PMID: 37918851